30. Perfluorocarbon Nanoparticles: A Multidimensional Platform for Targeted Image-Guided Drug Delivery

  1. Xiaoyuan Chen3,4
  1. Gregory M. Lanza1,†,
  2. Shelton D. Caruthers1,2,‡,
  3. Anne H. Schmieder1,
  4. Patrick M. Winter1,
  5. Tillmann Cyrus1 and
  6. Samuel A. Wickline1,§

Published Online: 25 MAY 2011

DOI: 10.1002/9780470767047.ch30

Nanoplatform-Based Molecular Imaging

Nanoplatform-Based Molecular Imaging

How to Cite

Lanza, G. M., Caruthers, S. D., Schmieder, A. H., Winter, P. M., Cyrus, T. and Wickline, S. A. (2011) Perfluorocarbon Nanoparticles: A Multidimensional Platform for Targeted Image-Guided Drug Delivery, in Nanoplatform-Based Molecular Imaging (ed X. Chen), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470767047.ch30

Editor Information

  1. 3

    Molecular Imaging Program at Stanford and Bio-X Program, Department of Radiology, Stanford University School of Medicine, Stanford, California, USA

  2. 4

    Laboratory for Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA

Author Information

  1. 1

    Department of Medicine, Washington University Medical School, St. Louis, Missouri, USA

  2. 2

    Philips Healthcare, Andover, Massachusetts, USA

  1. SAW and GML are scientific co-founders and minority stockholders of Kereos, Inc.

  2. SDC is an employee of Philips Healthcare

  3. §

    SAW and GML are scientific co-founders and minority stockholders of Kereos, Inc.

Publication History

  1. Published Online: 25 MAY 2011
  2. Published Print: 28 MAR 2011

ISBN Information

Print ISBN: 9780470521151

Online ISBN: 9780470767047

SEARCH

Keywords:

  • perfluorocarbon nanoparticles, a multidimensional platform - for targeted image-guided drug delivery, with targeted PFC nanoparticles in cancer and cardiovascular disease;
  • theranostic applications of perfluorocarbon nanoparticles in cancer - angiogenesis molecular imaging;
  • cardiovascular disease, and nanomedicine applications - using HMG-CoA reductase inhibitors for cardiovascular risk reduction, by LDL cholesterol lowering

Summary

This chapter contains sections titled:

  • Introduction

  • Perfluorocarbon Nanoparticles: An Overview

  • Perfluorocarbon Nanoparticles for Molecular Imaging

  • Theranostic Applications of Perfluorocarbon Nanoparticles in Cancer

  • Nanomedicine Applications in Cardiovascular Disease

  • Conclusion

  • References